Gervais R - Search Results

1

Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma.

Lesueur P, Chevalier F, Stefan D, Habrand JL, Lerouge D, Gervais R. Lesueur P, et al. Among authors: gervais r. Tumori. 2017 May 12;103(3):217-222. doi: 10.5301/tj.5000616. Epub 2017 Mar 3. Tumori. 2017. PMID: 28291902 Review.

2

Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting.

Sassier M, Dugué AE, Clarisse B, Lesueur P, Avrillon V, Bizieux-Thaminy A, Auliac JB, Kaluzinski L, Tillon J, Robinet G, Le Caer H, Monnet I, Madroszyk A, Boza G, Falchero L, Fournel P, Egenod T, Toffart AC, Leiber N, Do P, Gervais R. Sassier M, et al. Among authors: gervais r. Lung Cancer. 2015 Aug;89(2):161-6. doi: 10.1016/j.lungcan.2015.05.005. Epub 2015 May 15. Lung Cancer. 2015. PMID: 26037036

3

Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer.

Dumont D, Dô P, Lerouge D, Planchard G, Riffet M, Dubos-Arvis C, Danhier S, Gervais R. Dumont D, et al. Among authors: gervais r. Am J Case Rep. 2017 Aug 15;18:890-893. doi: 10.12659/ajcr.903528. Am J Case Rep. 2017. PMID: 28808224 Free PMC article.

4

Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review.

Lesueur P, Martel-Laffay I, Escande A, Kissel M, Locher C, Gervais R, Schott R, Vergnenegre A, Chouaid C. Lesueur P, et al. Among authors: gervais r. Expert Rev Anticancer Ther. 2018 Nov;18(11):1159-1165. doi: 10.1080/14737140.2018.1518714. Epub 2018 Sep 17. Expert Rev Anticancer Ther. 2018. PMID: 30173589

5

Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC.

Lesueur P, Escande A, Thariat J, Vauléon E, Monnet I, Cortot A, Lerouge D, Danhier S, Dô P, Dubos-Arvis C, Chouaïd C, Gervais R. Lesueur P, et al. Among authors: gervais r. Cancer Med. 2018 Nov;7(11):5505-5513. doi: 10.1002/cam4.1825. Epub 2018 Oct 11. Cancer Med. 2018. PMID: 30311424 Free PMC article.

6

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.

Kissel M, Martel-Lafay I, Lequesne J, Faivre JC, Le Péchoux C, Stefan D, Barraux V, Loiseau C, Grellard JM, Danhier S, Lerouge D, Chouaid C, Gervais R, Thariat J. Kissel M, et al. Among authors: gervais r. BMC Cancer. 2019 Dec 19;19(1):1237. doi: 10.1186/s12885-019-6449-8. BMC Cancer. 2019. PMID: 31856742 Free PMC article.

7

Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives.

Césaire M, Montanari J, Curcio H, Lerouge D, Gervais R, Demontrond P, Balosso J, Chevalier F. Césaire M, et al. Among authors: gervais r. Cancers (Basel). 2022 Jun 8;14(12):2829. doi: 10.3390/cancers14122829. Cancers (Basel). 2022. PMID: 35740495 Free PMC article. Review.

8

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer.

Gervais R, Hainsworth JD, Blais N, Besse B, Laskin J, Hamm JT, Lipton A, Albain KS, Masters GA, Natale RB, Selaru P, Kim ST, Chao RC, Page RD. Gervais R, et al. Lung Cancer. 2011 Dec;74(3):474-80. doi: 10.1016/j.lungcan.2011.05.004. Epub 2011 Jun 15. Lung Cancer. 2011. PMID: 21680048 Clinical Trial.

9

Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

Rambeau A, Gervais R, De Raucourt D, Babin E, Dugué AE, Florescu C, Blanchard D, Gery B. Rambeau A, et al. Among authors: gervais r. Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2883-2889. doi: 10.1007/s00405-017-4550-7. Epub 2017 Apr 5. Eur Arch Otorhinolaryngol. 2017. PMID: 28382396

10

Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.

Lasnon C, Hicks RJ, Beauregard JM, Milner A, Paciencia M, Guizard AV, Bardet S, Gervais R, Lemoel G, Zalcman G, Aide N. Lasnon C, et al. Among authors: gervais r. Clin Nucl Med. 2012 Oct;37(10):971-6. doi: 10.1097/RLU.0b013e318251e3d1. Clin Nucl Med. 2012. PMID: 22899197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page